Skip to main content
. Author manuscript; available in PMC: 2019 Mar 28.
Published in final edited form as: J Control Release. 2018 Jan 31;274:24–34. doi: 10.1016/j.jconrel.2018.01.028

Figure 3.

Figure 3

Outline of tumor vaccination with nanoparticle: A. Antigen encapsulated nanoparticle to activate peripheral dendritic cells. B. This immune-modulating nanoparticle triggers the adaptive immune responses through reactivation of CD8+ cytotoxic T cells to function against the specific tumorigenic proteins. The figure was obtained and reproduced from ref.[39] with permissions.